# The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects

> **NCT00856609** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 150 (actual)

## Conditions studied

- Weight Loss
- Obesity

## Interventions

- **DRUG:** Byetta (exenatide)
- **BEHAVIORAL:** Weight loss
- **OTHER:** Metabolic Chamber
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00856609
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-03
- **Primary completion:** 2016-09-19
- **Final completion:** 2016-09-19
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856609, "The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00856609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*